CKAP4 and Hyperglycemia: Moreover, HPODs exposed to hyperglycemia showed a significant decrease (Figure 1E) of CKAP4 expression at protein level, and a treatment with ADR, which is used as an injury model for focal segmental glomerulosclerosis, did not cause a reduction of CKAP4 in cultured HPODs.